The University of Chicago Header Logo

Connection

Richard Whitley to Humans

Back to Details
This is a "connection" page, showing publications Richard Whitley has written about Humans.
Richard Whitley
Connection Strength
1.688
Humans
  1. Shedding Patterns of Genital Herpes Simplex Virus Infections. JAMA. 2022 11 01; 328(17):1710-1711.
    View in: PubMed
    Score: 0.029
  2. Gastric herpes simplex virus type 1 infection is associated with functional gastrointestinal disorders in the presence and absence of comorbid fibromyalgia: a pilot case-control study. Infection. 2022 Oct; 50(5):1303-1311.
    View in: PubMed
    Score: 0.028
  3. Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat? Pediatr Infect Dis J. 2019 06; 38(6S Suppl 1):S60-S63.
    View in: PubMed
    Score: 0.023
  4. Clinical management of herpes simplex virus infections: past, present, and future. F1000Res. 2018; 7.
    View in: PubMed
    Score: 0.022
  5. Genital Herpes. N Engl J Med. 2016 11 10; 375(19):1906.
    View in: PubMed
    Score: 0.019
  6. CLINICAL PRACTICE. Genital Herpes. N Engl J Med. 2016 Aug 18; 375(7):666-74.
    View in: PubMed
    Score: 0.019
  7. Accelerating Drug Development: Antiviral Therapies for Emerging Viruses as a Model. Annu Rev Pharmacol Toxicol. 2017 01 06; 57:155-169.
    View in: PubMed
    Score: 0.019
  8. Oseltamivir for influenza - Authors' reply. Lancet. 2016 Jan 09; 387(10014):125.
    View in: PubMed
    Score: 0.018
  9. Herpes Simplex Virus Infections of the Central Nervous System. Continuum (Minneap Minn). 2015 Dec; 21(6 Neuroinfectious Disease):1704-13.
    View in: PubMed
    Score: 0.018
  10. Oseltamivir for influenza - Authors' reply. Lancet. 2015 Sep 19; 386(9999):1135-6.
    View in: PubMed
    Score: 0.018
  11. Editorial commentary: Waning efficacy of the herpes zoster vaccine. Clin Infect Dis. 2015 Mar 15; 60(6):910-1.
    View in: PubMed
    Score: 0.017
  12. The development of new therapies for human herpesvirus 6. Curr Opin Virol. 2014 Dec; 9:148-53.
    View in: PubMed
    Score: 0.017
  13. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials. Antivir Ther. 2015; 20(7):709-19.
    View in: PubMed
    Score: 0.017
  14. A novel potential therapy for HSV. N Engl J Med. 2014 Jan 16; 370(3):273-4.
    View in: PubMed
    Score: 0.016
  15. Herpes simplex virus. Handb Clin Neurol. 2014; 123:251-63.
    View in: PubMed
    Score: 0.016
  16. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis. 2013 May; 56(9):1197-205.
    View in: PubMed
    Score: 0.015
  17. An inquiry into the molecular basis of HSV latency and reactivation. Annu Rev Microbiol. 2013; 67:355-74.
    View in: PubMed
    Score: 0.015
  18. Changing epidemiology of herpes simplex virus infections. Clin Infect Dis. 2013 Feb; 56(3):352-3.
    View in: PubMed
    Score: 0.015
  19. Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12. J Virol. 2012 May; 86(9):5304-13.
    View in: PubMed
    Score: 0.014
  20. The use of antiviral drugs during the neonatal period. Clin Perinatol. 2012 Mar; 39(1):69-81.
    View in: PubMed
    Score: 0.014
  21. Antiviral drugs and antiviral drug resistance. Curr Opin Virol. 2011 Dec; 1(6):545-7.
    View in: PubMed
    Score: 0.014
  22. Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis. Pediatr Infect Dis J. 2011 Oct; 30(10):860-5.
    View in: PubMed
    Score: 0.014
  23. Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012 Jan; 53(1):6-11.
    View in: PubMed
    Score: 0.014
  24. Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol. 2011; 697:221-30.
    View in: PubMed
    Score: 0.013
  25. Treatment of herpes simplex virus infections in pediatric patients: current status and future needs. Clin Pharmacol Ther. 2010 Nov; 88(5):720-4.
    View in: PubMed
    Score: 0.013
  26. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol. 2010 May; 48 Suppl 1:S20-8.
    View in: PubMed
    Score: 0.012
  27. Of ferrets and humans: influenza pathogenesis. J Infect Dis. 2010 Apr 01; 201(7):976-7.
    View in: PubMed
    Score: 0.012
  28. Incomplete financial disclosures in an editorial, clinical crossroads, and reply letter related to herpes zoster. JAMA. 2010 Feb 24; 303(8):733-4.
    View in: PubMed
    Score: 0.012
  29. A 70-year-old woman with shingles: review of herpes zoster. JAMA. 2009 Jul 01; 302(1):73-80.
    View in: PubMed
    Score: 0.012
  30. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res. 2009 Sep; 83(3):207-13.
    View in: PubMed
    Score: 0.011
  31. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother. 2009 May; 63(5):862-7.
    View in: PubMed
    Score: 0.011
  32. Herpes zoster in the age of focused immunosuppressive therapy. JAMA. 2009 Feb 18; 301(7):774-5.
    View in: PubMed
    Score: 0.011
  33. Seasonal and pandemic influenza: a 2007 update on challenges and solutions. Clin Infect Dis. 2008 Apr 01; 46(7):1024-31.
    View in: PubMed
    Score: 0.011
  34. The new age of molecular diagnostics for microbial agents. N Engl J Med. 2008 Mar 06; 358(10):988-9.
    View in: PubMed
    Score: 0.011
  35. Neonatal herpes - the forgotten perinatal infection. Sex Transm Dis. 2008 Jan; 35(1):22-4.
    View in: PubMed
    Score: 0.010
  36. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008 Jan; 9(1 Suppl 1):S37-44.
    View in: PubMed
    Score: 0.010
  37. Therapy of herpes virus infections in children. Adv Exp Med Biol. 2008; 609:216-32.
    View in: PubMed
    Score: 0.010
  38. The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol. 2007 Oct; 3(5):755-67.
    View in: PubMed
    Score: 0.010
  39. Incidence of neonatal herpes simplex virus infections in a managed-care population. Sex Transm Dis. 2007 Sep; 34(9):704-8.
    View in: PubMed
    Score: 0.010
  40. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes. 2007 Sep; 14 Suppl 2:25-9.
    View in: PubMed
    Score: 0.010
  41. The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001. Clin Infect Dis. 2007 Oct 01; 45(7):881-2.
    View in: PubMed
    Score: 0.010
  42. Review of recent HSV recurrent-infection treatment studies. Herpes. 2007 Jun; 14(1):23-6.
    View in: PubMed
    Score: 0.010
  43. Current non-AIDS antiviral chemotherapy. Expert Rev Anti Infect Ther. 2007 Apr; 5(2):217-30.
    View in: PubMed
    Score: 0.010
  44. Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med. 2007 Mar 29; 356(13):1338-43.
    View in: PubMed
    Score: 0.010
  45. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
    View in: PubMed
    Score: 0.010
  46. Oncolytic HSV-1 for the treatment of brain tumours. Herpes. 2006 Nov; 13(3):66-71.
    View in: PubMed
    Score: 0.010
  47. Lessons learned from reconstructing the 1918 influenza pandemic. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S127-32.
    View in: PubMed
    Score: 0.010
  48. Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S133-8.
    View in: PubMed
    Score: 0.010
  49. Seasonal and pandemic influenza: recommendations for preparedness in the United States. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S155-61.
    View in: PubMed
    Score: 0.010
  50. Seasonal and pandemic influenza preparedness: a global threat. J Infect Dis. 2006 Nov 01; 194 Suppl 2:S65-9.
    View in: PubMed
    Score: 0.010
  51. Recurrent benign lymphocytic meningitis. Clin Infect Dis. 2006 Nov 01; 43(9):1194-7.
    View in: PubMed
    Score: 0.010
  52. New approaches to the therapy of HSV infections. Herpes. 2006 Aug; 13(2):53-5.
    View in: PubMed
    Score: 0.009
  53. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother. 2006 Jul; 50(7):2409-14.
    View in: PubMed
    Score: 0.009
  54. Single-day famciclovir therapy for recurrent genital herpes. Curr Med Res Opin. 2006 Jul; 22(7):1307-10.
    View in: PubMed
    Score: 0.009
  55. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006 Sep; 71(2-3):141-8.
    View in: PubMed
    Score: 0.009
  56. Neonatal herpes should be a reportable disease. Sex Transm Dis. 2005 Sep; 32(9):521-5.
    View in: PubMed
    Score: 0.009
  57. Changing dynamics of varicella-zoster virus infections in the 21st century: the impact of vaccination. J Infect Dis. 2005 Jun 15; 191(12):1999-2001.
    View in: PubMed
    Score: 0.009
  58. Human herpesvirus 6 infection of the central nervous system: is it just a case of mistaken association? Clin Infect Dis. 2005 Mar 15; 40(6):894-5.
    View in: PubMed
    Score: 0.009
  59. Neonatal herpes: what have we learned. Semin Pediatr Infect Dis. 2005 Jan; 16(1):7-16.
    View in: PubMed
    Score: 0.009
  60. Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis. 2005 Jan; 16(1):17-23.
    View in: PubMed
    Score: 0.009
  61. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 01; 39(9):1267-84.
    View in: PubMed
    Score: 0.008
  62. Commentary: Ch'ien LT, Cannon NJ, Charamella LJ, et al. effect of adenine arabinoside on severe herpesvirus hominis infections in man: preliminary report. J Infect Dis 1973; 128:658-63. J Infect Dis. 2004 Oct 01; 190(7):1360-7.
    View in: PubMed
    Score: 0.008
  63. Introduction: Is viral shedding a surrogate marker for transmission of genital herpes? Antiviral Res. 2004 Aug; 63 Suppl 1:S3-9.
    View in: PubMed
    Score: 0.008
  64. Lessons from HIV and hepatitis viruses. Antiviral Res. 2004 Aug; 63 Suppl 1:S11-8.
    View in: PubMed
    Score: 0.008
  65. HSV shedding. Antiviral Res. 2004 Aug; 63 Suppl 1:S19-26.
    View in: PubMed
    Score: 0.008
  66. HSV-2 transmission. Antiviral Res. 2004 Aug; 63 Suppl 1:S27-35.
    View in: PubMed
    Score: 0.008
  67. Cytomegalovirus and HIV: inextricably entwined pathogens. Lancet. 2004 Jun 26; 363(9427):2101-2.
    View in: PubMed
    Score: 0.008
  68. Neonatal herpes simplex virus infection. Curr Opin Infect Dis. 2004 Jun; 17(3):243-6.
    View in: PubMed
    Score: 0.008
  69. Congenital cytomegalovirus infection: epidemiology and treatment. Adv Exp Med Biol. 2004; 549:155-60.
    View in: PubMed
    Score: 0.008
  70. Issues in regulatory guidelines for data monitoring committees. Clin Trials. 2004; 1(2):162-9.
    View in: PubMed
    Score: 0.008
  71. Vertical mother-to-infant transmission of herpes simplex virus 2 is correlated with tropism due to mutations in viral UL13. J Med Virol. 2024 Jan; 96(1):e29379.
    View in: PubMed
    Score: 0.008
  72. Smallpox: a potential agent of bioterrorism. Antiviral Res. 2003 Jan; 57(1-2):7-12.
    View in: PubMed
    Score: 0.007
  73. Clinical practice. Herpes zoster. N Engl J Med. 2002 Aug 01; 347(5):340-6.
    View in: PubMed
    Score: 0.007
  74. Herpes simplex viruses: is a vaccine tenable? J Clin Invest. 2002 Jul; 110(2):145-51.
    View in: PubMed
    Score: 0.007
  75. Clinical applications for change-point analysis of herpes zoster pain. J Pain Symptom Manage. 2002 Jun; 23(6):510-6.
    View in: PubMed
    Score: 0.007
  76. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002 Feb 09; 359(9305):507-13.
    View in: PubMed
    Score: 0.007
  77. Herpes simplex virus infection. Semin Pediatr Infect Dis. 2002 Jan; 13(1):6-11.
    View in: PubMed
    Score: 0.007
  78. Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med. 2001 Aug 30; 20(16):2429-39.
    View in: PubMed
    Score: 0.007
  79. Herpes simplex virus infections. Lancet. 2001 May 12; 357(9267):1513-8.
    View in: PubMed
    Score: 0.007
  80. Genetically engineered human herpes simplex virus in the treatment of brain tumours. Herpes. 2001 Mar; 8(1):17-22.
    View in: PubMed
    Score: 0.007
  81. The nine ages of herpes simplex virus. Herpes. 2001 Mar; 8(1):23-7.
    View in: PubMed
    Score: 0.007
  82. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001 Feb; 20(2):127-33.
    View in: PubMed
    Score: 0.006
  83. Immunologic approach to herpes simplex virus. Viral Immunol. 2001; 14(2):111-8.
    View in: PubMed
    Score: 0.006
  84. Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors. Hum Gene Ther. 2020 10; 31(19-20):1132-1139.
    View in: PubMed
    Score: 0.006
  85. Genetically engineered HSV in the treatment of glioma: a review. Rev Med Virol. 2000 Jan-Feb; 10(1):17-30.
    View in: PubMed
    Score: 0.006
  86. Herpes zoster: focus on treatment in older adults. Antiviral Res. 1999 Dec 31; 44(3):145-54.
    View in: PubMed
    Score: 0.006
  87. Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease. Emerg Infect Dis. 2019 11; 25(11):2064-2073.
    View in: PubMed
    Score: 0.006
  88. Possible association of intussusception with rotavirus vaccination. American Academy of Pediatrics. Committee on Infectious Diseases. Pediatrics. 1999 Sep; 104(3 Pt 1):575.
    View in: PubMed
    Score: 0.006
  89. Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance. Oncogene. 2019 08; 38(34):6159-6171.
    View in: PubMed
    Score: 0.006
  90. Viral encephalitis. Pediatr Rev. 1999 Jun; 20(6):192-8.
    View in: PubMed
    Score: 0.006
  91. A mixed model for factors predictive of pain in AIDS patients with herpes zoster. J Pain Symptom Manage. 1999 Jun; 17(6):410-7.
    View in: PubMed
    Score: 0.006
  92. Cytomegalovirus retinitis--evolving therapies in a new era. N Engl J Med. 1999 Apr 08; 340(14):1109-10.
    View in: PubMed
    Score: 0.006
  93. Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population. mSphere. 2019 02 27; 4(1).
    View in: PubMed
    Score: 0.006
  94. Herpes zoster: risk categories for persistent pain. J Infect Dis. 1999 Jan; 179(1):9-15.
    View in: PubMed
    Score: 0.006
  95. Therapeutic approaches to the management of herpes zoster. Adv Exp Med Biol. 1999; 458:159-65.
    View in: PubMed
    Score: 0.006
  96. Approaches to the treatment of varicella-zoster virus infections. Contrib Microbiol. 1999; 3:158-72.
    View in: PubMed
    Score: 0.006
  97. Comparison of antiviral compounds against human herpesvirus 6 and 7. Antiviral Res. 1998 Dec; 40(1-2):73-84.
    View in: PubMed
    Score: 0.006
  98. The identification of risk factors associated with persistent pain following herpes zoster. J Infect Dis. 1998 Nov; 178 Suppl 1:S71-5.
    View in: PubMed
    Score: 0.006
  99. Human herpesvirus-6: neurologic implications of a newly-described viral pathogen. J Neurovirol. 1998 Oct; 4(5):474-85.
    View in: PubMed
    Score: 0.006
  100. Sexually transmitted diseases. Lancet. 1998 Aug 22; 352(9128):651.
    View in: PubMed
    Score: 0.005
  101. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
    View in: PubMed
    Score: 0.005
  102. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group. Antimicrob Agents Chemother. 1998 May; 42(5):1139-45.
    View in: PubMed
    Score: 0.005
  103. Summary of the III International Consensus Symposium on Combined Antiviral Therapy. Antiviral Res. 1998 May; 38(2):75-93.
    View in: PubMed
    Score: 0.005
  104. Herpes simplex viruses. Clin Infect Dis. 1998 Mar; 26(3):541-53; quiz 554-5.
    View in: PubMed
    Score: 0.005
  105. Antiviral therapy for neonatal herpes simplex virus: a cost-effectiveness analysis. Am J Manag Care. 1997 Oct; 3(10):1551-8.
    View in: PubMed
    Score: 0.005
  106. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997 May; 175(5):1080-6.
    View in: PubMed
    Score: 0.005
  107. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res. 1997 Apr 15; 57(8):1502-9.
    View in: PubMed
    Score: 0.005
  108. Treatment of viral infections during pregnancy and the neonatal period. Clin Perinatol. 1997 Mar; 24(1):267-83.
    View in: PubMed
    Score: 0.005
  109. New therapeutic approaches to the alphaherpesvirus infections. J Antimicrob Chemother. 1997 Feb; 39(2):119-28.
    View in: PubMed
    Score: 0.005
  110. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res. 1997 Jan; 33(2):73-85.
    View in: PubMed
    Score: 0.005
  111. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1996 Dec; 174(6):1162-7.
    View in: PubMed
    Score: 0.005
  112. Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. Antiviral Res. 1996 Nov; 32(3):119-40.
    View in: PubMed
    Score: 0.005
  113. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11313-8.
    View in: PubMed
    Score: 0.005
  114. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med. 1996 Sep 01; 125(5):376-83.
    View in: PubMed
    Score: 0.005
  115. The past as prelude to the future: history, status, and future of antiviral drugs. Ann Pharmacother. 1996 Sep; 30(9):967-71.
    View in: PubMed
    Score: 0.005
  116. Advances in the management of herpesvirus infections. Introduction. Semin Dermatol. 1996 Jun; 15(2 Suppl 1):1-3.
    View in: PubMed
    Score: 0.005
  117. Drug discovery for human immunodeficiency virus infection: conquests and hurdles. J Antimicrob Chemother. 1996 May; 37 Suppl B:151-9.
    View in: PubMed
    Score: 0.005
  118. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs. J Virol Methods. 1996 Apr 26; 58(1-2):137-43.
    View in: PubMed
    Score: 0.005
  119. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J. 1996 Mar; 15(3):247-54.
    View in: PubMed
    Score: 0.005
  120. Antiviral resistance: mechanisms, clinical significance, and future implications. J Antimicrob Chemother. 1996 Mar; 37(3):403-21.
    View in: PubMed
    Score: 0.005
  121. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996 Feb; 22(2):341-7.
    View in: PubMed
    Score: 0.005
  122. Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host. Antiviral Res. 1996 Jan; 29(1):67-8.
    View in: PubMed
    Score: 0.005
  123. Sorivudine: a potent inhibitor of varicella zoster virus replication. Adv Exp Med Biol. 1996; 394:41-4.
    View in: PubMed
    Score: 0.005
  124. Sorivudine: a promising drug for the treatment of varicella-zoster virus infection. Neurology. 1995 Dec; 45(12 Suppl 8):S73-5.
    View in: PubMed
    Score: 0.005
  125. Herpes zoster in patients with human immunodeficiency virus infection--an ever-expanding spectrum of disease. Clin Infect Dis. 1995 Oct; 21(4):989-90.
    View in: PubMed
    Score: 0.004
  126. Human herpesvirus 6 is associated with focal encephalitis. Clin Infect Dis. 1995 Sep; 21(3):571-6.
    View in: PubMed
    Score: 0.004
  127. Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995 Aug; 21 Suppl 1:S114-20.
    View in: PubMed
    Score: 0.004
  128. Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo. Viruses. 2015 Jul 30; 7(8):4230-53.
    View in: PubMed
    Score: 0.004
  129. Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. Clin Infect Dis. 2015 Sep 01; 61(5):683-91.
    View in: PubMed
    Score: 0.004
  130. A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis. J Pediatric Infect Dis Soc. 2016 Mar; 5(1):53-62.
    View in: PubMed
    Score: 0.004
  131. Antiviral resistance--an emerging problem. Antiviral Res. 1995 Apr; 26(4):365-8.
    View in: PubMed
    Score: 0.004
  132. Molecular mechanisms of antiviral resistance. Antiviral Res. 1995 Apr; 26(4):369-401.
    View in: PubMed
    Score: 0.004
  133. Assays for antiviral drug resistance. Antiviral Res. 1995 Apr; 26(4):403-13.
    View in: PubMed
    Score: 0.004
  134. Antiviral resistance in clinical practice. Antiviral Res. 1995 Apr; 26(4):423-38.
    View in: PubMed
    Score: 0.004
  135. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995 Apr; 171(4):857-63.
    View in: PubMed
    Score: 0.004
  136. Challenges and opportunities in developing respiratory syncytial virus therapeutics. J Infect Dis. 2015 Mar 15; 211 Suppl 1:S1-S20.
    View in: PubMed
    Score: 0.004
  137. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015 Mar 05; 372(10):933-43.
    View in: PubMed
    Score: 0.004
  138. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1411-5.
    View in: PubMed
    Score: 0.004
  139. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis. 1995 Feb; 20(2):414-20.
    View in: PubMed
    Score: 0.004
  140. Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics. Clin Infect Dis. 2015 May 01; 60(9):1377-83.
    View in: PubMed
    Score: 0.004
  141. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015 May 02; 385(9979):1729-1737.
    View in: PubMed
    Score: 0.004
  142. Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med. 2014 Aug 21; 371(8):711-22.
    View in: PubMed
    Score: 0.004
  143. Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines. Gene Ther. 2014 Nov; 21(11):984-90.
    View in: PubMed
    Score: 0.004
  144. The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach. Clin Pharmacol Ther. 2014 Sep; 96(3):380-9.
    View in: PubMed
    Score: 0.004
  145. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014 May 09; 14:248.
    View in: PubMed
    Score: 0.004
  146. Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention and therapy? Pediatr Infect Dis J. 1994 May; 13(5):432-8; discussion 438-9.
    View in: PubMed
    Score: 0.004
  147. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci U S A. 1994 Mar 29; 91(7):2441-7.
    View in: PubMed
    Score: 0.004
  148. What's the message? A content analysis of newspaper articles about assisted reproductive technology from 2005 to 2011. Hum Fertil (Camb). 2014 Jun; 17(2):124-32.
    View in: PubMed
    Score: 0.004
  149. A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses. Mol Ther. 2014 May; 22(5):1048-55.
    View in: PubMed
    Score: 0.004
  150. Prospects for vaccination against herpes simplex virus. Pediatr Ann. 1993 Dec; 22(12):726, 729-32.
    View in: PubMed
    Score: 0.004
  151. Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1. PLoS One. 2013; 8(11):e81768.
    View in: PubMed
    Score: 0.004
  152. Evaluation of new anti-infective drugs for the treatment of infection with human immunodeficiency virus. The European Working Party of the European Society of Clinical Microbiology and Infectious Diseases. Clin Infect Dis. 1993 Oct; 17(4):794-801.
    View in: PubMed
    Score: 0.004
  153. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013 Oct; 57(8):1114-28.
    View in: PubMed
    Score: 0.004
  154. Antiviral therapy: the time has come. J Med Virol. 1993; Suppl 1:1.
    View in: PubMed
    Score: 0.004
  155. Neonatal herpes simplex virus infections. J Med Virol. 1993; Suppl 1:13-21.
    View in: PubMed
    Score: 0.004
  156. Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis. 2013 Mar 01; 207(5):709-20.
    View in: PubMed
    Score: 0.004
  157. Evaluation of new anti-infective drugs for the treatment of viral encephalitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S195-9.
    View in: PubMed
    Score: 0.004
  158. Predictors of undiagnosed herpes simplex virus type 2 seropositivity among persons attending an HIV care clinic. Sex Transm Dis. 2012 Nov; 39(11):857-9.
    View in: PubMed
    Score: 0.004
  159. Acyclovir: a decade later. N Engl J Med. 1992 Sep 10; 327(11):782-9.
    View in: PubMed
    Score: 0.004
  160. Neonatal herpes simplex virus infections: pathogenesis and therapy. Pathol Biol (Paris). 1992 Sep; 40(7):729-34.
    View in: PubMed
    Score: 0.004
  161. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis. 1992 Aug; 166 Suppl 1:S51-7.
    View in: PubMed
    Score: 0.004
  162. Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients. Pediatr Transplant. 2012 Sep; 16(6):627-37.
    View in: PubMed
    Score: 0.004
  163. Prevalence of herpes simplex virus antibodies in dental students. J Dent Educ. 1992 Mar; 56(3):206-8.
    View in: PubMed
    Score: 0.003
  164. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5.
    View in: PubMed
    Score: 0.003
  165. Herpes simplex vaccines. Biotechnology. 1992; 20:223-54.
    View in: PubMed
    Score: 0.003
  166. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011 Oct 06; 365(14):1284-92.
    View in: PubMed
    Score: 0.003
  167. Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes. Drugs. 1991 Sep; 42(3):406-27.
    View in: PubMed
    Score: 0.003
  168. A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One. 2011; 6(7):e22527.
    View in: PubMed
    Score: 0.003
  169. Natural history and treatment of varicella-zoster in high-risk populations. J Hosp Infect. 1991 Jun; 18 Suppl A:317-29.
    View in: PubMed
    Score: 0.003
  170. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14; 324(7):444-9.
    View in: PubMed
    Score: 0.003
  171. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14; 324(7):450-4.
    View in: PubMed
    Score: 0.003
  172. Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group. J Infect Dis. 1991 Jan; 163(1):17-22.
    View in: PubMed
    Score: 0.003
  173. Moving toward elimination of healthcare-associated infections: a call to action. Am J Infect Control. 2010 Nov; 38(9):671-5.
    View in: PubMed
    Score: 0.003
  174. Oseltamivir dosing for influenza infection in premature neonates. J Infect Dis. 2010 Aug 15; 202(4):563-6.
    View in: PubMed
    Score: 0.003
  175. Viral encephalitis. N Engl J Med. 1990 Jul 26; 323(4):242-50.
    View in: PubMed
    Score: 0.003
  176. Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol. 1990 Jun; 47(6):646-7.
    View in: PubMed
    Score: 0.003
  177. Herpes simplex virus in African American heterosexual males: the roles of age and male circumcision. Sex Transm Dis. 2010 Apr; 37(4):217-22.
    View in: PubMed
    Score: 0.003
  178. Chickenpox: where do we stand with treatment? J Pediatr. 1990 Apr; 116(4):587.
    View in: PubMed
    Score: 0.003
  179. Reference values in pediatric medicine. Mayo Clin Proc. 1990 Mar; 65(3):431-5.
    View in: PubMed
    Score: 0.003
  180. Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. Pediatr Infect Dis J. 2010 Mar; 29(3):195-8.
    View in: PubMed
    Score: 0.003
  181. Acyclovir: the past ten years. Adv Exp Med Biol. 1990; 278:243-53.
    View in: PubMed
    Score: 0.003
  182. Novel pharmacological strategies in the treatment of life-threatening cytomegalovirus infections. Clinical experience with continuous infusion 9-(1,3-dihydroxy-2-propoxymethyl) guanine. Ann N Y Acad Sci. 1990; 616:452-60.
    View in: PubMed
    Score: 0.003
  183. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides. Antimicrob Agents Chemother. 2009 Dec; 53(12):5251-8.
    View in: PubMed
    Score: 0.003
  184. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009 Dec; 46 Suppl 4:S22-6.
    View in: PubMed
    Score: 0.003
  185. Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus. Pediatr Infect Dis J. 1989 Sep; 8(9):584-5.
    View in: PubMed
    Score: 0.003
  186. A role for herpes simplex virus type 1 glycoprotein E in induction of cell fusion. J Gen Virol. 1989 Aug; 70 ( Pt 8):2157-62.
    View in: PubMed
    Score: 0.003
  187. Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA. 1989 Jul 14; 262(2):234-9.
    View in: PubMed
    Score: 0.003
  188. Immunological alterations associated with recurrent herpes simplex genitalis. Clin Immunol Immunopathol. 1989 May; 51(2):294-302.
    View in: PubMed
    Score: 0.003
  189. Intrauterine herpes simplex virus infection. Teratology. 1989 Jan; 39(1):1-10.
    View in: PubMed
    Score: 0.003
  190. Neonatal herpes simplex virus infections. Clin Perinatol. 1988 Dec; 15(4):903-16.
    View in: PubMed
    Score: 0.003
  191. Antibody response of the newborn after herpes simplex virus infection. J Infect Dis. 1988 Nov; 158(5):925-33.
    View in: PubMed
    Score: 0.003
  192. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther. 2009 Jan; 17(1):199-207.
    View in: PubMed
    Score: 0.003
  193. Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure. Liver Transpl. 2008 Oct; 14(10):1498-504.
    View in: PubMed
    Score: 0.003
  194. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007. Herpes. 2008 Oct; 15(1):4-12.
    View in: PubMed
    Score: 0.003
  195. Herpes simplex virus infections of the central nervous system. A review. Am J Med. 1988 Aug 29; 85(2A):61-7.
    View in: PubMed
    Score: 0.003
  196. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008 Aug 01; 47(3):303-27.
    View in: PubMed
    Score: 0.003
  197. An isoelectric focusing study in herpes simplex virus encephalitis. Ann Neurol. 1988 Aug; 24(2):227-32.
    View in: PubMed
    Score: 0.003
  198. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis. 1988 Jul; 158(1):109-16.
    View in: PubMed
    Score: 0.003
  199. Isolated Cryptococcus neoformans osteomyelitis in an immunocompetent child. Pediatr Infect Dis J. 1988 Apr; 7(4):289-92.
    View in: PubMed
    Score: 0.003
  200. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008 Mar 15; 197(6):836-45.
    View in: PubMed
    Score: 0.003
  201. Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections? Ann Intern Med. 1988 Mar; 108(3):452-4.
    View in: PubMed
    Score: 0.003
  202. Condylomata acuminata in IDDM. Diabetes Care. 1988 Mar; 11(3):295-6.
    View in: PubMed
    Score: 0.003
  203. The frustrations of treating herpes simplex virus infections of the central nervous system. JAMA. 1988 Feb 19; 259(7):1067.
    View in: PubMed
    Score: 0.003
  204. Natural history and pathogenesis of neonatal herpes simplex virus infections. Ann N Y Acad Sci. 1988; 549:103-17.
    View in: PubMed
    Score: 0.003
  205. Antiviral treatment of a serious herpes simplex infection: encephalitis. J Am Acad Dermatol. 1988 Jan; 18(1 Pt 2):209-11.
    View in: PubMed
    Score: 0.003
  206. Yes, brain biopsy should be a prerequisite for herpes simplex encephalitis treatment. Arch Neurol. 1987 Dec; 44(12):1289-90.
    View in: PubMed
    Score: 0.003
  207. Condyloma acuminatum: epidemiological, clinical and therapeutic aspects. Eur J Epidemiol. 1987 Sep; 3(3):209-15.
    View in: PubMed
    Score: 0.003
  208. Transfusion-associated viral infections. Curr Probl Pediatr. 1987 Jul; 17(7):391-443.
    View in: PubMed
    Score: 0.003
  209. Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity. J Clin Immunol. 1987 Jul; 7(4):304-11.
    View in: PubMed
    Score: 0.003
  210. Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis. J Infect Dis. 1987 Jun; 155(6):1172-8.
    View in: PubMed
    Score: 0.003
  211. An update on short-course intermittent and prevention therapies for herpes labialis. Herpes. 2007 Jun; 14 Suppl 1:13A-18A.
    View in: PubMed
    Score: 0.003
  212. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007 Jun; 81(6):867-72.
    View in: PubMed
    Score: 0.002
  213. Antiviral therapy and pulmonary disease. Chest. 1987 Feb; 91(2):246-51.
    View in: PubMed
    Score: 0.002
  214. Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract. 2007 Jan; 56(1):30-6.
    View in: PubMed
    Score: 0.002
  215. Approaches to therapy of viral infections. Adv Pediatr. 1987; 34:89-110.
    View in: PubMed
    Score: 0.002
  216. Therapy of viral infections in children. Adv Pediatr Infect Dis. 1987; 2:35-56.
    View in: PubMed
    Score: 0.002
  217. Detection of antibodies to herpes simplex virus in the cerebrospinal fluid of patients with herpes simplex encephalitis. J Infect Dis. 1987 Jan; 155(1):38-44.
    View in: PubMed
    Score: 0.002
  218. Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis. Infection. 1987; 15 Suppl 1:S3-8.
    View in: PubMed
    Score: 0.002
  219. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis. 2007 Jan 15; 44(2):245-9.
    View in: PubMed
    Score: 0.002
  220. Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors. Cancer Gene Ther. 2007 Jan; 14(1):45-56.
    View in: PubMed
    Score: 0.002
  221. Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors. J Virol. 2006 Aug; 80(15):7308-15.
    View in: PubMed
    Score: 0.002
  222. Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cells. J Immunol. 1986 Jun 01; 136(11):4243-8.
    View in: PubMed
    Score: 0.002
  223. Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies. Virology. 1986 Jun; 151(2):385-9.
    View in: PubMed
    Score: 0.002
  224. Replication of varicella zoster virus in Raji cells. Virus Res. 1986 Jun; 4(4):337-42.
    View in: PubMed
    Score: 0.002
  225. Neonatal herpes simplex virus infections. Presentation and management. J Reprod Med. 1986 May; 31(5 Suppl):426-32.
    View in: PubMed
    Score: 0.002
  226. Regulatory challenges: lessons from recent West Nile virus trials in the United States. Contemp Clin Trials. 2006 Jun; 27(3):254-9.
    View in: PubMed
    Score: 0.002
  227. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. J Clin Microbiol. 1986 Apr; 23(4):725-30.
    View in: PubMed
    Score: 0.002
  228. Analysis of DNA from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion. Sex Transm Dis. 1986 Apr-Jun; 13(2):61-6.
    View in: PubMed
    Score: 0.002
  229. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol. 2006 Mar; 194(3):774-81.
    View in: PubMed
    Score: 0.002
  230. The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic. J Infect Dis. 2006 Apr 01; 193(7):905-11.
    View in: PubMed
    Score: 0.002
  231. CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy. Neurol Clin. 1986 Feb; 4(1):265-83.
    View in: PubMed
    Score: 0.002
  232. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16; 314(3):144-9.
    View in: PubMed
    Score: 0.002
  233. Herpesvirus infections in the immunocompromised host: diagnosis and management. Adv Exp Med Biol. 1986; 202:95-118.
    View in: PubMed
    Score: 0.002
  234. Brain biopsy for encephalitis. Clin Neurosurg. 1986; 33:591-602.
    View in: PubMed
    Score: 0.002
  235. Herpesvirus infections of pregnancy. Part II: Herpes simplex virus and varicella-zoster virus infections. N Engl J Med. 1985 Nov 21; 313(21):1327-30.
    View in: PubMed
    Score: 0.002
  236. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985 Nov 14; 313(20):1270-4.
    View in: PubMed
    Score: 0.002
  237. Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J Virol. 1985 Nov; 56(2):419-25.
    View in: PubMed
    Score: 0.002
  238. Psychosis and herpes simplex encephalitis. South Med J. 1985 Nov; 78(11):1347-50.
    View in: PubMed
    Score: 0.002
  239. A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl. 2005 Aug; 11(8):941-9.
    View in: PubMed
    Score: 0.002
  240. Historical correlates of genital herpes simplex virus type 2 infection in men attending an STD clinic. Sex Transm Infect. 2005 Aug; 81(4):303-5.
    View in: PubMed
    Score: 0.002
  241. High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine. Antimicrob Agents Chemother. 1985 Aug; 28(2):265-73.
    View in: PubMed
    Score: 0.002
  242. Parvovirus infection: chance and investigation. N Engl J Med. 1985 Jul 11; 313(2):111-2.
    View in: PubMed
    Score: 0.002
  243. Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model. Neuro Oncol. 2005 Jul; 7(3):213-24.
    View in: PubMed
    Score: 0.002
  244. Therapy for human herpesvirus infections. A perspective. Ala J Med Sci. 1985 Apr; 22(2):193-207.
    View in: PubMed
    Score: 0.002
  245. Design of therapeutic studies in herpes simplex encephalitis. Lancet. 1985 Feb 02; 1(8423):284-5.
    View in: PubMed
    Score: 0.002
  246. Therapeutic challenges of neonatal herpes simplex virus infection. Scand J Infect Dis Suppl. 1985; 47:97-106.
    View in: PubMed
    Score: 0.002
  247. Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis. 2005 Jan 15; 191(2):227-33.
    View in: PubMed
    Score: 0.002
  248. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004 Nov 01; 39(9):1307-13.
    View in: PubMed
    Score: 0.002
  249. Medical pathology conference. Headache, fever, abnormal behavior, and dysphasia in an elderly man. Ala J Med Sci. 1984 Oct; 21(4):399-406.
    View in: PubMed
    Score: 0.002
  250. Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. 1973. J Infect Dis. 2004 Oct 01; 190(7):1362-7.
    View in: PubMed
    Score: 0.002
  251. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis. 1984 Sep; 150(3):323-9.
    View in: PubMed
    Score: 0.002
  252. Treatment of human herpesvirus infections with special reference to encephalitis. J Antimicrob Chemother. 1984 Aug; 14 Suppl A:57-74.
    View in: PubMed
    Score: 0.002
  253. Therapeutic approaches to the control of cytomegalovirus infections. Birth Defects Orig Artic Ser. 1984; 20(1):345-52.
    View in: PubMed
    Score: 0.002
  254. Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host. J Infect Dis. 1984 Jan; 149(1):1-8.
    View in: PubMed
    Score: 0.002
  255. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics. 1983 Dec; 72(6):778-85.
    View in: PubMed
    Score: 0.002
  256. Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: vidarabine versus acyclovir. J Antimicrob Chemother. 1983 Sep; 12 Suppl B:105-12.
    View in: PubMed
    Score: 0.002
  257. Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy. 1983 Sep-Oct; 3(5):275-83.
    View in: PubMed
    Score: 0.002
  258. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003 Jul; 143(1):16-25.
    View in: PubMed
    Score: 0.002
  259. Management of infections. Pediatr Ann. 1983 Jun; 12(6):445-9.
    View in: PubMed
    Score: 0.002
  260. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J. 2003 Apr; 22(4):335-41.
    View in: PubMed
    Score: 0.002
  261. Towards therapy and prevention of herpetic infections. Semin Perinatol. 1983 Jan; 7(1):64-81.
    View in: PubMed
    Score: 0.002
  262. Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982 Oct 21; 307(17):1060-2.
    View in: PubMed
    Score: 0.002
  263. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med. 1982 Oct 14; 307(16):971-5.
    View in: PubMed
    Score: 0.002
  264. Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin Microbiol Infect. 2002 Sep; 8(9):551-63.
    View in: PubMed
    Score: 0.002
  265. Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents. Am J Med. 1982 Jul 20; 73(1A):236-40.
    View in: PubMed
    Score: 0.002
  266. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals. Am J Med. 1982 Jul 20; 73(1A):165-71.
    View in: PubMed
    Score: 0.002
  267. Vidarabine therapy of varicella in immunosuppressed patients. J Pediatr. 1982 Jul; 101(1):125-31.
    View in: PubMed
    Score: 0.002
  268. Herpes simplex encephalitis and clinical trial design. Lancet. 1982 May 01; 1(8279):1013.
    View in: PubMed
    Score: 0.002
  269. Herpesvirus infections in childhood: diagnostic dilemmas and therapy. Pediatr Infect Dis. 1982 Mar-Apr; 1(2):81-4.
    View in: PubMed
    Score: 0.002
  270. Herpes simplex encephalitis. Clinical Assessment. JAMA. 1982 Jan 15; 247(3):317-20.
    View in: PubMed
    Score: 0.002
  271. The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma. Gene Ther. 2002 Jan; 9(1):75-80.
    View in: PubMed
    Score: 0.002
  272. Prevention of hepatitis B in adolescents. Pediatrics. 2001 Dec; 108(6):1392.
    View in: PubMed
    Score: 0.002
  273. Preventive and therapeutic approaches to the newborn infant with perinatal viral and toxoplasma infections. Clin Perinatol. 1981 Oct; 8(3):591-604.
    View in: PubMed
    Score: 0.002
  274. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001 Aug; 108(2):223-9.
    View in: PubMed
    Score: 0.002
  275. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001 Aug; 108(2):230-8.
    View in: PubMed
    Score: 0.002
  276. Antiviral agents: clinical status report. Hosp Pract (Off Ed). 1981 Jul; 16(7):109-21.
    View in: PubMed
    Score: 0.002
  277. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med. 1981 Feb 05; 304(6):313-8.
    View in: PubMed
    Score: 0.002
  278. Diagnosis and treatment of herpes simplex encephalitis. Annu Rev Med. 1981; 32:335-40.
    View in: PubMed
    Score: 0.002
  279. Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans. Antimicrob Agents Chemother. 1980 Nov; 18(5):709-15.
    View in: PubMed
    Score: 0.002
  280. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 1980 Oct; 66(4):489-94.
    View in: PubMed
    Score: 0.002
  281. Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. Drugs. 1980 Oct; 20(4):267-82.
    View in: PubMed
    Score: 0.002
  282. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. 1980 Oct; 66(4):495-501.
    View in: PubMed
    Score: 0.002
  283. Herpes simplex encephalitis: need for accurate diagnosis. JAMA. 1980 Jul 25; 244(4):371-2.
    View in: PubMed
    Score: 0.002
  284. Plasma levels and urinary excretion of vidarabine after repeated dosing. Clin Pharmacol Ther. 1980 May; 27(5):690-6.
    View in: PubMed
    Score: 0.002
  285. Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A. 2000 Feb 29; 97(5):2208-13.
    View in: PubMed
    Score: 0.002
  286. Effect of recombinant human interferon alpha B/D (rHu-IFN-alpha B/D) in combination with acyclovir in experimental HSV-1 encephalitis. Antiviral Res. 1999 Nov; 44(1):75-8.
    View in: PubMed
    Score: 0.001
  287. Clinical significance of enteroviruses in serious summer febrile illnesses of children. Pediatr Infect Dis J. 1999 Oct; 18(10):869-74.
    View in: PubMed
    Score: 0.001
  288. Distribution of adenine arabinoside and interferon. JAMA. 1979 Sep 21; 242(12):1259-60.
    View in: PubMed
    Score: 0.001
  289. Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus. Clin Cancer Res. 1999 Jun; 5(6):1517-22.
    View in: PubMed
    Score: 0.001
  290. Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors. Cancer Res. 1999 May 01; 59(9):2055-8.
    View in: PubMed
    Score: 0.001
  291. Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. Am J Ophthalmol. 1999 Mar; 127(3):329-39.
    View in: PubMed
    Score: 0.001
  292. Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections. Adv Ophthalmol. 1979; 38:288-96.
    View in: PubMed
    Score: 0.001
  293. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol. 1998 Oct; 179(4):846-51.
    View in: PubMed
    Score: 0.001
  294. Current status of antiviral chemotherapy. South Med J. 1978 Sep; 71(9):1134-40.
    View in: PubMed
    Score: 0.001
  295. NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med. 1978 Sep; 89(3):375-88.
    View in: PubMed
    Score: 0.001
  296. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol. 1998 Aug; 36(8):2229-34.
    View in: PubMed
    Score: 0.001
  297. Molecular epidemiology of p53 protein mutations in workers exposed to vinyl chloride. Am J Epidemiol. 1998 Feb 01; 147(3):302-8.
    View in: PubMed
    Score: 0.001
  298. Developmental aspects of selected antiviral chemotherapeutic agents. Annu Rev Microbiol. 1978; 32:285-300.
    View in: PubMed
    Score: 0.001
  299. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. J Med Assoc State Ala. 1977 Sep; 47(3):37-42, 66.
    View in: PubMed
    Score: 0.001
  300. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11; 297(6):289-94.
    View in: PubMed
    Score: 0.001
  301. Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J. 1997 Apr; 16(4):409-11.
    View in: PubMed
    Score: 0.001
  302. Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Antimicrob Agents Chemother. 1996 Sep; 40(9):2202-5.
    View in: PubMed
    Score: 0.001
  303. Differential effect of recombinant human and mouse interferons on replication of herpes simplex virus type 1 in mouse cells. Antiviral Res. 1996 Aug; 32(1):27-34.
    View in: PubMed
    Score: 0.001
  304. Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection. J Pediatr. 1976 Jul; 89(1):16-22.
    View in: PubMed
    Score: 0.001
  305. Treatment of infections due to Herpesvirus in humans: a critical review of the state of the art. J Infect Dis. 1976 Jun; 133 Suppl:A101-8.
    View in: PubMed
    Score: 0.001
  306. Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27; 294(22):1193-9.
    View in: PubMed
    Score: 0.001
  307. Therapy of herpetic infections in man: a status report. Adv Pathobiol. 1976; (5):159-72.
    View in: PubMed
    Score: 0.001
  308. The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials. Control Clin Trials. 1995 Dec; 16(6):408-21.
    View in: PubMed
    Score: 0.001
  309. Neonatal herpes simplex virus infection. Int Ophthalmol Clin. 1975; 15(4):141-9.
    View in: PubMed
    Score: 0.001
  310. A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents. J Virol Methods. 1994 Jul; 48(2-3):273-9.
    View in: PubMed
    Score: 0.001
  311. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med. 1993 Oct 07; 329(15):1065-72.
    View in: PubMed
    Score: 0.001
  312. A rabbit model for human cytomegalovirus-induced chorioretinal disease. J Infect Dis. 1993 Aug; 168(2):336-44.
    View in: PubMed
    Score: 0.001
  313. Diabetes insipidus associated with symptomatic congenital cytomegalovirus infection. J Pediatr. 1993 Jun; 122(6):911-3.
    View in: PubMed
    Score: 0.001
  314. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis. 1992 Dec; 15(6):1031-8.
    View in: PubMed
    Score: 0.001
  315. Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S182-8.
    View in: PubMed
    Score: 0.001
  316. Evaluation of new anti-infective drugs for the treatment of cryptococcal meningitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S189-94.
    View in: PubMed
    Score: 0.001
  317. Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992 Nov; 15 Suppl 1:S200-5.
    View in: PubMed
    Score: 0.001
  318. Transmission of herpes simplex virus type 1 infection in an intensive care unit. Ann Intern Med. 1992 Oct 01; 117(7):584-6.
    View in: PubMed
    Score: 0.001
  319. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr. 1992 Apr; 120(4 Pt 1):627-33.
    View in: PubMed
    Score: 0.001
  320. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis. 1991 Dec; 164(6):1196-9.
    View in: PubMed
    Score: 0.001
  321. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med. 1991 Nov 28; 325(22):1539-44.
    View in: PubMed
    Score: 0.001
  322. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis. 1991 Jul; 164(1):72-80.
    View in: PubMed
    Score: 0.001
  323. Humanized antibodies for antiviral therapy. Proc Natl Acad Sci U S A. 1991 Apr 01; 88(7):2869-73.
    View in: PubMed
    Score: 0.001
  324. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science. 1990 Nov 30; 250(4985):1262-6.
    View in: PubMed
    Score: 0.001
  325. Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet. 1990 Feb 24; 335(8687):440-1.
    View in: PubMed
    Score: 0.001
  326. Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon. Viral Immunol. 1990; 3(3):217-24.
    View in: PubMed
    Score: 0.001
  327. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial. Am J Med. 1988 Sep; 85(3):301-6.
    View in: PubMed
    Score: 0.001
  328. Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trial. Ann Intern Med. 1988 May; 108(5):675-9.
    View in: PubMed
    Score: 0.001
  329. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet. 1988 Jan 2-9; 1(8575-6):1-4.
    View in: PubMed
    Score: 0.001
  330. Congenital cytomegalovirus: immunological alterations. J Med Virol. 1987 Sep; 23(1):41-9.
    View in: PubMed
    Score: 0.001
  331. Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers. Antimicrob Agents Chemother. 1987 Sep; 31(9):1317-22.
    View in: PubMed
    Score: 0.001
  332. Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A. 1987 Jun; 84(12):4303-7.
    View in: PubMed
    Score: 0.001
  333. Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells. J Immunol. 1987 Feb 15; 138(4):1229-33.
    View in: PubMed
    Score: 0.001
  334. T-cell imbalances and NK activity in varicella-zoster virus infections. Viral Immunol. 1987; 1(2):145-52.
    View in: PubMed
    Score: 0.001
  335. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics. 1987 Jan; 79(1):76-83.
    View in: PubMed
    Score: 0.001
  336. Diagnosis of viral encephalitis by brain biopsy. Semin Diagn Pathol. 1984 May; 1(2):71-81.
    View in: PubMed
    Score: 0.001
  337. Prophylactic or anticipatory antiviral therapy for newborns exposed to herpes simplex infection. Pediatr Infect Dis. 1984 May-Jun; 3(3):193-5.
    View in: PubMed
    Score: 0.001
  338. Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virus. Virus Res. 1984 Jan; 1(1):81-7.
    View in: PubMed
    Score: 0.000
  339. ELISA for the detection of herpes simplex virus antigens in the cerebrospinal fluid of patients with encephalitis. J Virol Methods. 1983 Sep; 7(3):117-25.
    View in: PubMed
    Score: 0.000
  340. Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis. 1983 Jun; 147(6):1119-20.
    View in: PubMed
    Score: 0.000
  341. Experience with brain biopsy for suspected herpes encephalitis: a review of forty consecutive cases. Neurosurgery. 1983 Jun; 12(6):654-7.
    View in: PubMed
    Score: 0.000
  342. Repeated suppression of Creutzfeldt-Jakob disease with vidarabine. Lancet. 1982 Sep 04; 2(8297):564-5.
    View in: PubMed
    Score: 0.000
  343. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis. 1982 Jun; 145(6):829-36.
    View in: PubMed
    Score: 0.000
  344. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy. Infect Immun. 1981 Oct; 34(1):166-70.
    View in: PubMed
    Score: 0.000
  345. Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics. 1981 Sep; 68(3):322-9.
    View in: PubMed
    Score: 0.000
  346. Rapid detection of viruses in biopsy or autopsy specimens by the pseudoreplica method of electron microscopy. Am J Surg Pathol. 1981 Sep; 5(6):565-72.
    View in: PubMed
    Score: 0.000
  347. Cytomegalovirus infection in patients with renal transplants: potentiation by antithymocyte globulin and an incompatible graft. J Infect Dis. 1980 Jul; 142(1):9-17.
    View in: PubMed
    Score: 0.000
  348. Herpes zoster in early infancy. Am J Dis Child. 1980 Jun; 134(6):618-9.
    View in: PubMed
    Score: 0.000
  349. Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther. 1979 Dec; 26(6):718-28.
    View in: PubMed
    Score: 0.000
  350. Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation. Transplantation. 1979 Dec; 28(6):443-6.
    View in: PubMed
    Score: 0.000
  351. Serum antibody levels as risk factors in the dissemination of herpes zoster. Arch Intern Med. 1979 Dec; 139(12):1341-5.
    View in: PubMed
    Score: 0.000
  352. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis. 1979 Oct; 140(4):487-92.
    View in: PubMed
    Score: 0.000
  353. Outcome of renal transplantation in patients with primary cytomegalovirus infection. Transplant Proc. 1979 Jun; 11(2):1288-90.
    View in: PubMed
    Score: 0.000
  354. Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis. Virology. 1978 Dec; 91(2):234-42.
    View in: PubMed
    Score: 0.000
  355. Herpes simplex virus encephalitis: an atypical presentation. South Med J. 1978 Nov; 71(11):1431-3.
    View in: PubMed
    Score: 0.000
  356. Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study. J Infect Dis. 1976 Jun; 133 Suppl:A184-91.
    View in: PubMed
    Score: 0.000
  357. Cerebellar hypoplasia in an infant with congenital cytomegalovirus infection. Pediatrics. 1976 Jan; 57(1):155-7.
    View in: PubMed
    Score: 0.000
  358. Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics. 1975 May; 55(5):678-85.
    View in: PubMed
    Score: 0.000
  359. Effect of adenine arabinoside on cytomegalovirus infections. J Infect Dis. 1974 Jul; 130(1):32-9.
    View in: PubMed
    Score: 0.000
  360. Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis. 1973 Nov; 128(5):658-63.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.